High RIPK3 expression is associated with a higher risk of early kidney transplant failure.

Wahida, A., Schmaderer, C., Buttner-Herold, M., Branca, C., Donakonda, S., Haberfellner, F., Torrez, C., Schmitz, J., Schulze, T., Seibt, T., Ollinger, R., Engleitner, T., Haller, B., Steiger, K., Gunthner, R., Lorenz, G., Yabal, M., Bachmann, Q., Braunisch, M.C., Moog, P., Matevossian, E., Assfalg, V., Thorban, S., Renders, L., Spath, M.R., Muller, R.U., Stippel, D.L., Weichert, W., Slotta-Huspenina, J., von Vietinghoff, S., Viklicky, O., Green, D.R., Rad, R., Amann, K., Linkermann, A., Brasen, J.H., Heemann, U., Kemmner, S. (2023). iScience 26, 107879.



Renal ischemia-reperfusion injury (IRI) is associated with reduced allograft survival, and each additional hour of cold ischemia time increases the risk of graft failure and mortality following renal transplantation. Receptor-interacting protein kinase 3 (RIPK3) is a key effector of necroptosis, a regulated form of cell death. Here, we evaluate the first-in-human RIPK3 expression dataset following IRI in kidney transplantation. The primary analysis included 374 baseline biopsy samples obtained from renal allografts 10 minutes after onset of reperfusion. RIPK3 was primarily detected in proximal tubular cells and distal tubular cells, both of which are affected by IRI. Time-to-event analysis revealed that high RIPK3 expression is associated with a significantly higher risk of one-year transplant failure and prognostic for one-year (death-censored) transplant failure independent of donor and recipient associated risk factors in multivariable analyses. The RIPK3 score also correlated with deceased donation, cold ischemia time and the extent of tubular injury.